লোডিং...
Gene expression signature in advanced colorectal cancer patients select drugs and response for the use of leucovorin, fluorouracil, and irinotecan
PURPOSE: In patients with advanced colorectal cancer, FOLFIRI is considered as one of the reference first-line treatments. However, only about half of treated patients respond to this bi-therapy, and there is no clinically useful marker that predicts response. A major clinical challenge is to identi...
সংরক্ষণ করুন:
| প্রধান লেখক: | , , , , , , , , , , , , , , , |
|---|---|
| বিন্যাস: | Artigo |
| ভাষা: | Inglês |
| প্রকাশিত: |
American Society of Clinical Oncology
2007
|
| বিষয়গুলি: | |
| অনলাইন ব্যবহার করুন: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2257989/ https://ncbi.nlm.nih.gov/pubmed/17327601 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2006.07.4187 |
| ট্যাগগুলো: |
ট্যাগ যুক্ত করুন
কোনো ট্যাগ নেই, প্রথমজন হিসাবে ট্যাগ করুন!
|